Active	Status	Sponsor type	Region	Phase	Filter
4 Active 3 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Szegedi, Laszlo L
NCT06195774: Effect of Epidural Analgesia on Regional Lung Ventilation in Parturient Women as Assessed by Thoracic Impedance	Not yet recruiting	N/A	100	Europe		Erasme University Hospital	Pregnancy Complications, Atelectasis	12/25	12/26
ERASME ULB, NCT06563557: Erasme Randomized Controlled Trial Surveys Hemodynamic Excursions During Esophagectomy	Not yet recruiting	N/A	75	NA	Hemodynamic changes between epidural and paravertebral during esophagectomy	Erasme University Hospital	Esophagectomy, Epidural; Anesthesia, Paravertebral Anesthesia, Hemodynamic Instability	08/26	12/26
Erfan, Jozsef
EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer	Recruiting	3	6000	Europe, Canada, Japan, US, RoW	Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane	Eli Lilly and Company	Breast Neoplasms	10/27	03/32
OpcemISA, NCT03669718 / 2018-000789-13: A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC	Active, not recruiting	2	194	Europe, US, RoW	ISA101b, Cemiplimab, Placebo	ISA Pharmaceuticals, Regeneron Pharmaceuticals	Squamous Cell Carcinoma of the Oropharynx, HPV16 Positive	09/24	06/25